Form 4: Corcept Therapeutics Director Daniel N. Swisher Jr. Executes Stock Options and Sells Shares
SEC Form 4 Filing
Director Daniel N. Swisher Jr. of Corcept Therapeutics exercised stock options and sold shares on May 12, 2025, according to a Form 4 filing with the SEC.
Summary
- On May 12, 2025, Daniel N. Swisher Jr., a director of Corcept Therapeutics, exercised stock options to acquire 1,800 shares at $12.13 and 400 shares at $14.08.
- Simultaneously, Swisher sold 1,800 shares at $72.17 and 400 shares at $71.55.
- These transactions were executed under a pre-arranged 10b5-1 trading plan adopted on August 1, 2024.
- Following these transactions, Swisher directly owns 0 shares of common stock.
- Swisher also holds options to purchase 12,100 shares of common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard disclosure of insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives and directors to have pre-arranged trading plans (10b5-1) to avoid accusations of trading on inside information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Date of adoption of the 10b5-1 trading plan. |
| 05/12/2025 | Date of the transactions: exercising stock options and selling shares. |
| 05/14/2025 | Date of the Form 4 filing. |
| 05/24/2027 | Expiration date of some stock options. |
| 08/20/2028 | Expiration date of some stock options. |
Keywords
Form 4, Corcept Therapeutics, Stock Options, Insider Trading, Daniel N. Swisher Jr., CORT, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.